Aims: It is known that a decrease in the amount of acetylcholine in the body, which is known to be responsible for learning and cholinergic activity in the nervous system, causes Alzheimer’s disease. Acetylcholine is destroyed by acetylcholinesterase (AChE) and Butyrylcholinesterase (BChE) enzymes in the nervous system. Consolida orientalis (C. orientalis) is a species that belongs to the Ranunculaceae family and grows naturally in many parts of the world. It is known that it plays a role in many biological activities thanks to its content of important phytochemical components such as phenolics and alkaloids. In this study; It was aimed to investigate the antioxidant activity, AChE and BChE enzyme inhibition activities of C. orientalis flower extracts.
Methods: The chemical content of ethanol extracts obtained from the flowers of C. orientalis plant, which was collected and identified from Sivas İmaret village between June and July 2023, was examined with 6 different reference substances (gallic acid, rosmarinic acid, myrcetin, quercetin, apigenin and camphorol). Antioxidant activity was determined by 2,2-Diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) tests. Ascorbic acid and trolox were used as positive controls. The inhibition capacity of the samples on AChE and BChE enzymes was determined by the Ellman method.
Results: Chemical content analysis of the extract was performed by high pressure liquid chromatography (HPLC) and only gallic acid was detected among the standard compounds. When C. orientalis ethanol extracts were examined with DPPH and ABTS tests, they showed low-moderate antioxidant activity (IC50 (µg/ml) DPPH=4.8, IC50 (µg/ml) ABTS=4.4) compared to standard substances. C. orientalis ethanol extract was studied at a concentration of 20 µg/ml. The extract inhibited the AChE enzyme at 66.5% and the BChE enzyme at 53.2%. It was observed that the extract inhibited both enzymes at moderate to good levels, although not higher than galantamine used as positive control.
Conclusion: This study shows us that C. orientalis flowers have therapeutic potential for the effective management of neurological disorders due to their antioxidant and anticholinesterase activity. It is thought that our data will contribute to the literature as a preliminary study for the development of a new phytotherapeutic agent in the treatment of Alzheimer’s disease.
Acetylcholinesterase Alzheimer’s disease antioxidant butyrylcholinesterase Consolida orientalis
Primary Language | English |
---|---|
Subjects | Translational and Applied Bioinformatics, Health Services and Systems (Other) |
Journal Section | Original Article |
Authors | |
Publication Date | October 27, 2024 |
Submission Date | August 21, 2024 |
Acceptance Date | October 22, 2024 |
Published in Issue | Year 2024 Volume: 7 Issue: 6 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.